Decoding the Host Response to Infection Requires Comprehensive, Accessible Solutions

Infection can sometimes present as a medical mystery, leaving clinicians with diagnostic uncertainty—unable to confirm the presence of an infection or its etiology. And critical decisions often need to be made based on incomplete or fragmented data from multiple tests, with each representing only a piece of the puzzle. Unraveling the complexities of infection requires the right combination of clinical biomarkers for deeper understanding of the patient condition.

The Host Response to Infection Tells a Powerful Story—And We’re Listening

Building upon our strong history of biomarker innovation, we are transforming the diagnostic landscape to help reduce diagnostic fragmentation, improve understanding of the host response to infection, and support overall patient health.

We are leading the way with novel clinical biomarkers and a comprehensive, cross-disciplinary portfolio—rethinking diagnostics to provide actionable insights into patient care.

Leveraging Established, Novel, and Emerging Biomarkers

We are committed to identifying biomarkers that aid in the assessment
of the host response and underlying conditions.